Logo-aim
Original Article

1. Neoadjuvant Chemotherapy in Patients with HER2-Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran
Kamran Roudini ORCID, Mehrzad Mirzania, Tahereh Yavari, Monireh Sadat Seyyedsalehi, Azin Nahvijou, Jayran Zebardast, Mina Saadat, Ahmad Khajeh-Mehrizi* ORCID
Arch Iran Med. 2024;27(4): 206-215. doi: 10.34172/aim.2024.30
Article
PDF
XML
Cited By:
0
Original Article

2. Predictors of Recurrent Urolithiasis in Iran: Findings from a Nationwide Study
Abbas Basiri ORCID, Amir Hossein Kashi, Mazyar Zahir* ORCID, Nasrin Borumandnia, Maryam Taheri, Shabnam Golshan, Behzad Narouie, Hayat Mombeini
Arch Iran Med. 2024;27(4): 200-205. doi: 10.34172/aim.2024.29
Article
PDF
XML
Cited By:
0
Original Article

3. A Scoring System to Determine the Risk Factors Causing Recurrent Pulmonary Thromboembolism
Mutlu Onur Gucsav* ORCID, Dursun Tatar ORCID
Arch Iran Med. 2023;26(7): 374-380. doi: 10.34172/aim.2023.57
PMCID: PMC10685820     PMID: 38301096     Scopus ID: 85175653337    
Article
PDF
XML
Cited By:
0
0
0
Photoclinic

4. Extramedullary Manifestation of Multiple Myeloma in the Oral Cavity
Cristiano de Assis Pereira Hansen*, Jayr Schmidt Filho, Marina de Mattos Nascimento, Fábio Abreu Alves, Tatiane Neotti, Felipe D´Almeida Costa
Arch Iran Med. 2018;21(12): 611-612.
PMID: 30634861     Scopus ID: 85059917618    
Article
PDF
XML
Cited By:
0
0

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.